OSU Wants Subjects For Trials Of COVID-19 Medications
Ohio State University researchers are seeking people to participate in two clinical trials studying therapeutic medications for COVID-19.
One is a trial of what is called a neutralizing antibody for patients who test positive but don't require hospitalization.
Researchers are also conducting a high-risk exposure trial of the Regeneron neutralizing antibody cocktail used to treat President Trump. That trial needs participants who have been exposed to known COVID and timing is critical. They’ll start this trial next week.
More information is available at the Coronavirus Prevention Network website.